Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190121042444N1
IRCT20190121042444N1
Completed
Phase 3

Evaluating the Effect of Dexmedetomidine Infusion on Gene Expression of Inflammatory Cytokines & Lymphocyte T CD4 + Transcription Factors in Elective Abdominal Aortic Aneurysm Repair

Shahid Beheshti University of Medical Sciences0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with abdominal aortic aneurysms referring to Shohadaye Tajrish Hospital who are candidates for elective aneurysm repair surgery will be included in the study.

Exclusion Criteria

  • •Previous history of aortic surgery
  • •ASA Class III and above
  • •Malignancies
  • •Chronic inflammatory diseases
  • •Taking corticosteroids
  • •Emergency surgery
  • •Any unstable patient during surgery
  • •Any addiction

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Drug therapy for improving the renal function after kidney transplantatioEnd-stage renal disease.Chronic kidney disease, stage 5
IRCT2017101331487N5Vice-chancellor for Research, Iran University of Medical Sciences50
Not yet recruiting
Phase 4
To study the effects of Dexmedetomidine on blood parameters of adult patients undergoing Head surgery
CTRI/2020/09/027762Vardhaman Mahavir Medical College and Safdarjang Hospital
Recruiting
Phase 2
Evaluation of Dexmedetomidine effect on mentally-disabled adults, candidate for dental treatment under general aneasthesia
IRCT20190626044013N2Esfahan University of Medical Sciences50
Completed
Not Applicable
Studying the effect of intravenous dexmedetomidine on spinal anaesthesia with bupivacaine. Dexmedetomidine is an alpha agonist drug known to prolong the effects of spinal anaesthesia. Bupivacaine is a local anaesthetic.Health Condition 1: null- American Society of Anaesthesiologists Physical Status 1 or 2
CTRI/2015/01/005431Manipal University75
Completed
Not Applicable
Comparing Dexmedetomidine and Propofol infusion as added anesthetic drugs in patients undergoing Trans nasal Trans sphenoidal excision of pituitary tumor surgeries
CTRI/2020/07/026811Amrita Institute of Medical Sciences and Research Centre48